Prof. Dr. MEHMET UFUK ABACIOGLU

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery , cilt.269, ss.275-82, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

46. Information for Decision Making by Patients With Early-Stage Prostate Cancer: A Comparison Across 9 Countries

Feldman-Stewart D., Capirci C., Brennenstuhl S., Tong C., ABACIOGLU M. U., Gawkowska-Suwinska M., et al.

MEDICAL DECISION MAKING , cilt.31, sa.5, ss.754-766, 2011 (SCI-Expanded)

47. Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma

ABACIOGLU M. U., Caglar H. B., Yumuk P. F., Akgun Z., ATASOY B. M., Sengoz M.

JOURNAL OF NEURO-ONCOLOGY , cilt.103, sa.3, ss.585-593, 2011 (SCI-Expanded)

48. Concomitant chemoradiotherapy with low-dose weekly gemcitabine for nonmetastatic unresectable pancreatic cancer

ATASOY B. M., Dane F., ÜÇÜNCÜ KEFELİ A., Caglar H., CİNGİ A., Turhal N. S., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.22, sa.1, ss.60-64, 2011 (SCI-Expanded)

49. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.

Kocher M., Soffietti R., Abacioglu U., Villà S., Fauchon F., Baumert B., et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology , cilt.29, ss.134-41, 2011 (SCI-Expanded)

50. Patient Reported Toxicity in Men Treated with 3D Conformal Techniques for Localized Prostate Cancer: A Turkish Oncology Group (TOG) Study

Igdem S., Alco G., DİNÇBAŞ H. F., ABACIOGLU M. U., Kilic D., YALMAN D., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.81, sa.2, 2011 (SCI-Expanded)

51. Adenoid cystic carcinoma of the Bartholin's gland: case report and systematic review of the literature

Cetin I. A., Vinh-Hung V., EREN F., ABACIOGLU M. U.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , cilt.32, sa.5, ss.567-572, 2011 (SCI-Expanded)

52. Does the Timing of Radiotherapy Impact Survival of Glioblastoma Multiforme Patients?

Tezcanli E. K., Ucuncu A., SARIHAN S., Aksu A., EROĞLU C., Alco G., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.81, sa.2, 2011 (SCI-Expanded)

53. Pulmonary toxicity in patients receiving docetaxel chemotherapy

Yumuk P. F., KEFELİ U., CEYHAN B., Dane F., Eroglu B. T., Gumus M., et al.

MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1381-1388, 2010 (SCI-Expanded)

54. Prophylactic feeding with immune-enhanced diet ameliorates chemoradiation-induced gastrointestinal injury in rats

ATASOY B. M., Deniz M., Dane F., Ozen Z., Turan P., ERCAN F., et al.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , cilt.86, sa.10, ss.867-879, 2010 (SCI-Expanded)

55. Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ)

Malmstrom A., Gronberg B. H., Stupp R., Marosi C., Frappaz D., Schultz H. P., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.18, 2010 (SCI-Expanded)

56. Outcomes of gamma knife treatment for solid intracranial hemangioblastomas

Karabagli H., Genc A., Karabagli P., ABACIOGLU M. U., Seker A., Kilic T.

JOURNAL OF CLINICAL NEUROSCIENCE , cilt.17, sa.6, ss.706-710, 2010 (SCI-Expanded)

57. Radiotherapy with or without temozolomide in elderly glioblastoma patients: Treatment results and prognostic factors.

Dirier A., Abacioglu M. U., Okkan S., Pak Y., Guney Y. Y., Aksu G., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded)

58. S1354 The Impact of Prophylactic Percutaneus Endoscopic Gastrostomy to Nutritional Status and Quality of Life in Locally Advanced Head and Neck Cancer Patients Receiving Chemoradiotherapy

Yonal O., Atasoy B. M., Demirel B., Yilmaz Y., Dane F., Abacioglu U., et al.

GASTROENTEROLOGY , cilt.138, sa.5, ss.235, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

59. Quality-of-life results of an EORTC phase III randomized trial of adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases of solid tumors

Soffietti R., Mueller R. P., Abacioglu M. U., Villa S., Fauchon F., Baumert B., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.28, sa.15, 2010 (SCI-Expanded)

60. Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: A retrospective rare cancer network study

Nguyen T. D., Azria D., Brochon D., Poortmans P., Miller R. C., Scandolaro L., et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.74, sa.1, ss.66-71, 2010 (SCI-Expanded)

61. Gamma knife stereotactic radiosurgery yields good long-term outcomes for low-volume uveal melanomas without intraocular complications

Toktas Z. O., Bicer A., Demirci G., Pazarli H., ABACIOGLU M. U., Peker S., et al.

JOURNAL OF CLINICAL NEUROSCIENCE , cilt.17, sa.4, ss.441-445, 2010 (SCI-Expanded)

62. Gamma knife radiosurgery in non small cell lung cancer patients with brain metastases: treatment results and prognostic factors.

Abacioglu U., Caglar H., Atasoy B., Abdulloev T., Akgun Z., Kilic T.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.15, ss.274-80, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

63. Information needs of early-stage prostate cancer patients: A comparison of nine countries

Feldman-Stewart D., Capirci C., Brennenstuhl S., Tong C., ABACIOGLU M. U., Gawkowska-Suwinska M., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.94, sa.3, ss.328-333, 2010 (SCI-Expanded)

64. Gamma knife radiosurgery for the treatment of glomus jugulare tumors

Genc A., Bicer A., ABACIOGLU M. U., Peker S., Pamir M. N., Kilic T.

JOURNAL OF NEURO-ONCOLOGY , cilt.97, sa.1, ss.101-108, 2010 (SCI-Expanded)

65. Impact of percent positive random biopsies on biochemical outcome in prostate cancer patients treated with external beam radiotherapy with or without androgen deprivation

Igdem S., ABACIOGLU M. U., Cetin I., Alco G., Akgun Z., Sengoz M., et al.

JOURNAL OF BUON , cilt.14, sa.4, ss.629-634, 2009 (SCI-Expanded)

66. Analysis of p53 Gene Polymorphisms and Protein Over-expression in Patients with Breast Cancer

AKKİPRİK M., Sonmez O., GÜLLÜOĞLU M. B., Caglar H. B., KAYA H., Demirkalem P., et al.

PATHOLOGY & ONCOLOGY RESEARCH , cilt.15, sa.3, ss.359-368, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

67. Postoperative radiotherapy for prostate cancer: Sooner or later?

Igdem S., Abacioglu M. U., Alço G., Ibrahimov R., Kefeli A., Çetin I., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.27, sa.15_suppl, ss.16157, 2009 (SCI-Expanded)

68. Dosimetric analysis for thyroid disorders after radiotherapy to the neck

Akgun Z., Atasoy B., Ozen Z., Gulluoglu B., Abacioglu M. U.

JOURNAL OF CLINICAL ONCOLOGY , cilt.27, sa.15_suppl, ss.17025, 2009 (SCI-Expanded)

69. Efficacy of protracted dose-dense temozolomide (TMZ) in patients with progressive high-grade glioma

Abacioglu M. U., Caglar H. B., Yumuk P. F., Akgun Z., Atasoy B. M., Sengoz M.

JOURNAL OF CLINICAL ONCOLOGY , cilt.27, sa.15_suppl, ss.13018, 2009 (SCI-Expanded)

70. Small Cell (Neuroendocrine) Carcinoma of the Prostate: Etiology, Diagnosis, Prognosis, and Therapeutic Implications-A Retrospective Study of 30 Patients From the Rare Cancer Network

Stein M. E., Bernstein Z., ABACIOGLU M. U., Sengoz M., Miller R. C., Meirovitz A., et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES , cilt.336, sa.6, ss.478-488, 2008 (SCI-Expanded)

71. Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience

Dane F., Gumus M., Ozturk M. A., Cabuk D., Atasoy M. B., Yumuk P. F., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.26, sa.15, 2008 (SCI-Expanded)

72. Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN)

Goldberg H., Miller R. C., Abdah-Bortnyak R., Steiner M., YILDIZ F., Meirovitz A., et al.

GYNECOLOGIC ONCOLOGY , cilt.108, sa.2, ss.298-305, 2008 (SCI-Expanded)

73. Toxicity and feasibility analysis for cisplatin-based concomitant chemoradiotherapy in locally advanced nasopharyngeal carcinoma

ATASOY B. M., Dane F., Yumuk R., Akguen Z., Turhal N. S., ABACIOGLU M. U., et al.

JOURNAL OF BUON , cilt.13, sa.1, ss.43-50, 2008 (SCI-Expanded)

74. Pituitary adenomas treated with gamma knife radiosurgery: Volumetric analysis of 100 cases with minimum 3 year follow-up

Pamir M. N., Kilic T., Belirgen M., ABACIOGLU M. U., Karabekiroglu N.

NEUROSURGERY , cilt.61, sa.2, ss.270-280, 2007 (SCI-Expanded)

75. P2-323: Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

Yumuk P. F., Teomete M., Dane F., Cabuk D., Caglar H. B., Abacioglu U., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.2, sa.8, ss.701, 2007 (SCI-Expanded)

76. Prognostic effect of Ki-67 proliferation index in glioblastoma multiforme

ABACIOGLU M. U., Gucluer B., Cetin I., Akgun Z., Tezcanli E. K., Sengoz M., et al.

VIRCHOWS ARCHIV , cilt.451, sa.2, ss.192, 2007 (SCI-Expanded)

77. Clinical outcome of node-negative (NN) breast cancer (BC) patients

BAŞARAN G., Cabuk D., Dane F., Teomete M., Iyikesici S., Meltem E., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.25, sa.18, 2007 (SCI-Expanded)

78. Concomitant administration of uracil-tegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer

ATASOY B. M., ABACIOGLU M. U., Dane F., Ozgen Z., Yumuk P. F., Ozden S., et al.

JOURNAL OF BUON , cilt.12, sa.2, ss.203-208, 2007 (SCI-Expanded)

79. Hodgkin's disease in the nasopharynx.

Atasoy B., Abacioğlu U., Oztürk O., Ozdemir R., Tecimer T.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.11, ss.529-31, 2006 (SCI-Expanded)

80. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A Rare Cancer Network study

ÖZYAR E., Selek U., Laskar S., Uzel O., Anacak Y., Ben-Arush M., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.81, sa.1, ss.39-46, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

81. Adjuvant radiotheraphy in prostate cancer Prostat kanserinde adjuvant radyoterapi

Abacioǧlu U., Türkeri L.

Turk Uroloji Dergisi , cilt.32, sa.3, ss.298-304, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

82. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: A retrospective study from the rare cancer network

Weber D. C., Miller R. C., Villa S., Hanssens P., Baumert B. G., Castadot P., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.66, sa.1, ss.179-186, 2006 (SCI-Expanded)

83. Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network

Omlin A., Amichetti M., Azria D., Cole B. F., Fourneret P., Poortmans P., et al.

LANCET ONCOLOGY , cilt.7, sa.8, ss.652-656, 2006 (SCI-Expanded)

84. Outcome of rectal carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital

Dane F., Gumus M., Iyikesici S., Yumuk F., Basaran G., Atasoy B. M., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.24, sa.18_suppl, ss.13584, 2006 (SCI-Expanded)

85. Tolerability assessment of urasil-tegafur (UFT)/folinic acid (FA) as concurrent chemoradiation (CRT) in adjuvant rectal cancer treatment

Atasoy B. M., Abacioglu U., Ozgen Z., Dane F., Yumuk F., Akgun Z., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.24, sa.18_suppl, ss.13559, 2006 (SCI-Expanded)

86. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules

Cengiz M., ÖZYAR E., Esassolak M., Altun M., Akmansu M., ŞEN M., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.63, sa.5, ss.1347-1353, 2005 (SCI-Expanded)

87. Cerebellar gliobastomas multiforme in adults: a rare cancer network study on 31 patients

Weber D. C., Miller R. C., Villa S., Hanssens P., Castadot P., Varlet P., et al.

EJC SUPPLEMENTS , cilt.3, sa.2, ss.138, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

88. Impact of percent positive biopsies on biochemical outcome in prostate cancer patients treated with external beam radiotherapy with or without androgen deprivation

Iqdem S., ABACIOGLU M. U., Cetin I., Alco G., Akgun Z., Sengoz M., et al.

EJC SUPPLEMENTS , cilt.3, sa.2, ss.233, 2005 (SCI-Expanded)

89. Gamma knife stereotactic radiosurgery for nasopharyngeal carcinoma

Atasoy B. M., ABACIOGLU M. U., Faker S., Kilic T., Sengoz M., Pamir N.

EJC SUPPLEMENTS , cilt.3, sa.2, ss.411, 2005 (SCI-Expanded)

90. Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer

ABACIOGLU M. U., Yumuk P., Caglar H., Sengoz M., Turhal N.

BMC CANCER , cilt.5, 2005 (SCI-Expanded)

91. Prognostic significance of MIB-1 labeling indices for oligodendroglial tumors

Abacioglu U., Sengoz M., Tezcanli E., Akpulat S., Peker S., Sav A.

JOURNAL OF CLINICAL ONCOLOGY , cilt.23, sa.16_suppl, ss.1533, 2005 (SCI-Expanded)

92. Gamma knife radiosurgery for cavernous sinus plasmacytoma in a patient with breast cancer history

Peker S., ABACIOGLU M. U., Bayrakli F., Kilic T., Pamir M.

SURGICAL NEUROLOGY , cilt.63, sa.2, ss.174-177, 2005 (SCI-Expanded)

93. Does the incidence of anal canal cancers differ in Moslem societies?

Yumuk P., ABACIOGLU M. U., Demir G., Cabuk D., Dane F., Gumus M., et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE , cilt.20, sa.1, ss.76, 2005 (SCI-Expanded)

94. Irradiation after surgically induced brain injury in the rat: timing in relation to severity of radiation damage

Peker S., ABACIOGLU M. U., Sun I., YÜKSEL M., Pamir M.

JOURNAL OF NEURO-ONCOLOGY , cilt.70, sa.1, ss.17-21, 2004 (SCI-Expanded)

95. Integration of a problem-based multidisciplinary clinical cancer management course into undergraduate education

ABACIOGLU M. U., Sarikaya O., Iskit S., Sengoz M.

JOURNAL OF CANCER EDUCATION , cilt.19, sa.3, ss.144-148, 2004 (SCI-Expanded)

96. Prophylactic effects of magnesium and vitamin E in rat spinal cord radiation damage: evaluation based on lipid peroxidation levels

Peker S., ABACIOGLU M. U., Sun I., Konya D., YÜKSEL M., Pamir N.

LIFE SCIENCES , cilt.75, sa.12, ss.1523-1530, 2004 (SCI-Expanded)

97. Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC)

Abacioglu U., Yumuk P. F., Caglar H., Sengoz M., Turhal N. S.

JOURNAL OF CLINICAL ONCOLOGY , cilt.22, sa.14_suppl, ss.7318, 2004 (SCI-Expanded)

98. Is the incidence of anal canal cancers different in Moslem societies?

Cabuk D., Yumuk P. F., Abacioglu U., Demir G., Dane F., Gumus M., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.22, sa.14_suppl, ss.4233, 2004 (SCI-Expanded)

99. Outcome of rectal and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in marmara university hospital

Yumuk P., ABACIOGLU M. U., Caglar H., Gumus M., Sengoz M., Turhal N.

JOURNAL OF CHEMOTHERAPY , cilt.15, sa.6, ss.603-606, 2003 (SCI-Expanded)

100. Partial intestinal obstruction due to childhood refractory hon-Hodgkin's lymphoma, successfully treated with taxol.

Berrak S., Türkkan E., Canpolat C., Iskit S., Dağli T., Abacioğlu U.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie , cilt.13, ss.276-9, 2003 (SCI-Expanded)

101. PSA bouncing after external beam radiation for prostate cancer with or without hormonal treatment

Sengoz M., ABACIOGLU M. U., ALSAN ÇETİN İ., Turkeri L.

EUROPEAN UROLOGY , cilt.43, sa.5, ss.473-477, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

102. Extrapulmonary small cell carcinoma: Multimodality treatment results

Sengoz M., ABACIOGLU M. U., Salepci T., EREN F., Yumuk F., Turhal S.

TUMORI , cilt.89, sa.3, ss.274-277, 2003 (SCI-Expanded)

103. Medulloblastoma in adults: Treatment results and prognostic factors

ABACIOGLU M. U., Uzel O., Sengoz M., Turkan S., Ober A.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.54, sa.3, ss.855-860, 2002 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler 21

1. An Evaluation of the Feasibility and Utility of Automated HyperArc Planning for Multiple Brain Metastases: A Comparative Dosimetric Analysis

Şenkesen Ö., İspir E. B., Özen Z., Abacıoglu M. U.

Acıbadem Üniversitesi Sağlık Bilimleri Dergisi , cilt.16, sa.4, ss.560-566, 2025 (Hakemli Dergi)

2. Current Clinical Practices in Glioblastoma Management: A Nationwide Survey of Radiation Oncologists, TROD 07-004 Study

ATASOY B. M., Akgün Z., ABACIOGLU M. U., Oysul K.

Turk Onkoloji Dergisi , cilt.40, sa.2, ss.133-140, 2025 (ESCI)

3. Magnetic Resonance Imaging-Guided Stereotactic Body Radiation Therapy for Medically Inoperable Endometrial Cancer

Dincer N., Abacıoglu M. U., Tezcanli E. K., Gungor G., Sengoz M.

CUREUS JOURNAL OF MEDICAL SCIENCE , sa.2, 2023 (ESCI)

4. Limited field adaptive radiotherapy for glioblastoma: changes in target volume and organ at risk doses

Şenkesen Ö., Tezcanli E. K., Abacıoglu M. U., Ozen Z., Cone D., Kucucuk H., et al.

RADIATION ONCOLOGY JOURNAL , cilt.40, sa.1, ss.9-19, 2022 (ESCI)

5. Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience

UĞURLUER G., Mustafayev T. Z., GUNGOR G., ATALAR B., ABACIOGLU M. U., ŞENGÖZ K. M., et al.

RADIATION ONCOLOGY JOURNAL , cilt.39, sa.1, ss.33-40, 2021 (Hakemli Dergi)

6. CECOG experts' recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer

Hilbe W., Abacioglu U., Aebersold D. M., Bachouchi M., Brodowicz T., Gaafar R., et al.

Memo - Magazine of European Medical Oncology , cilt.6, sa.2, ss.75-82, 2013 (Hakemli Dergi) Sürdürülebilir Kalkınma

7. Chemoradiotherapy Experience in Locally Advanced Esophageal Cancer

ALSAN ÇETİN İ., Yumuk P. F. O., ATASOY B. M., Dane F., Caglar H. B., Ibrahimov R., et al.

MARMARA MEDICAL JOURNAL , cilt.25, sa.2, ss.74-77, 2012 (ESCI)

8. Interdisciplinary Collaboration in Management of Nutrition during Chemoradiotherapy in Cancer Patients: A Pilot Study

ATASOY B. M., Ozgen Z., Kantas O. Y., Demirel B., Aksu A., Dane F., et al.

MARMARA MEDICAL JOURNAL , cilt.25, sa.1, ss.32-36, 2012 (ESCI)

9. A rare primary pulmonary tumor in children; Rhabdomyosarcoma

Türkkan E., Berrak S. G., Canpolat C., Ergüven M., Abacioglu U., Fedakar A.

Marmara Medical Journal , cilt.23, sa.1, 2010 (Hakemli Dergi)

10. T4N0M0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology?

Atasoy B. M., Ozyar E., Akman F., Esassolak M., Abacioǧlu U.

Kulak burun boǧaz ihtisas dergisi : KBB = Journal of ear, nose, and throat , cilt.20, sa.2, ss.89-96, 2010 (Scopus)

11. Cisplatin-based concomitant chemoradiotherapy in locally advanced squamous cell carcinoma of head and neck: Toxicity and feasibility analysis Lokal ileri evre skuamöz hücreli baş ve boyun kanserinde sisplatinle eş zamanli kemoradyoterapi: Yan etki ve uygulanabilirlik analizi

ATASOY B. M., Dane F., Sari M., Akgün Z., Yumuk P. F., Turhal N. S., et al.

Turk Onkoloji Dergisi , cilt.23, sa.1, ss.1-11, 2008 (Scopus) Sürdürülebilir Kalkınma

12. Preoperative radiotherapy with concomitant fluoropyrimidine-based chemotherapy for resectable locally advanced rectal cancer

ATASOY B. M., Dane F., Caglar H., Tezcanli E. K., CİNGİ A., ABACIOGLU M. U., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.23, sa.4, ss.163-171, 2008 (ESCI)

13. GRANULOCYTE COLONY STIMULATING FACTOR AMELIORATES RADIATION-INDUCED MORPHOLOGICAL DESTRUCTION OF INTESTINAL MUCOSA IN RATS

ATASOY B. M., Gungor-Gulluoglu M., ABACIOGLU M. U., Deniz M., Sengoz M., YEGEN B.

MARMARA MEDICAL JOURNAL , cilt.21, sa.1, ss.1-6, 2008 (ESCI)

14. Radiothérapie àvisée curative danslesadénocarcinomes deprostate localisés survenant après 80ans. Une étude duRare Cancer Network

Nguyen T., Azria D., Brochon D., Poortmans P., Miller R., Scandolaro L., et al.

Cancer/Radiothérapie , cilt.11, sa.6-7, ss.414, 2007 (Scopus)

15. A comparison of conventional external radiotherapy technique and conformal radiotherapy technique in terms of acute toxicity with regard to hormonal treatment

ALSAN ÇETİN İ., Abacioǧlu U., Şengöz M.

Marmara Medical Journal , cilt.17, sa.2, ss.58-64, 2004 (Scopus) Sürdürülebilir Kalkınma

16. Lokal İleri ve Metastatik Küçük Hücreli Dışı Akciğer Kanseri Hastalarının Değerlendirilmesi Marmara Üniversitesi Deneyimi

Yumuk P. F., Iyikesici M. S., Gümüş M., Aliustaoğlu M., Dane F., Başaran G., et al.

Türk Onkoloji Dergisi , cilt.19, sa.3, ss.106-111, 2004 (Hakemli Dergi) Sürdürülebilir Kalkınma

17. Hazards of radiotherapy in patients with cardiac pacemaker: A case report and review of the literature

Abaciocǧlu M. U., Dirican B., Ulutin H. C., Pak Y.

THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.13, sa.2, ss.87-91, 2003 (Scopus)

18. FACTORS INFLUENCING RELAPSE-FREE SURVIVAL IN PROSTATE CANCER PATIENTS AFTER DEFINITIVE RADIOTHERAPY

ŞENGÖZ K. M., BALTALARLI P. B., ALSAN ÇETİN İ., ABACIOĞLU M. U., ŞENKESEN Ö., ÖZEN Z., et al.

TURKISH JOURNAL OF ONCOLOGY , cilt.17, ss.59-65, 2002 (Hakemli Dergi) Sürdürülebilir Kalkınma

19. Survival and prognostic factor analysis in whole brain irradiation of patients with brain metastases

ABACIOĞLU U., ŞENGÖZ K. M., ATASOY B. M.

Marmara Medical Journal , cilt.14, sa.1, ss.7-11, 2001 (Scopus)

20. THE PHYSICAL PRINCIPLES OF GAMMAKNIFE THERAPY

ŞENGÖZ K. M., BALTALARLI P. B., ÖZEN Z., ŞENKESEN Ö., ABACIOĞLU M. U., ATASOY B. M., et al.

TURKISH JOURNAL OF ONCOLOGY , , cilt.14, sa.2, ss.94-99, 1999 (Hakemli Dergi)

21. 617Combined radiotherapy and chemotherapy in carcinoma of the cervix: Results of a randomised study

Okkan S., Atkovar G., Şahinler Í., Abacioglu U., Oruç N.

Radiotherapy and Oncology , cilt.40, ss.157, 1996 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 71

1. The Results of Re-Irradiation in Pediatric Recurrent Central Nervous System Tumors

İribaş Çelik A., Özkaya Toraman K., Abacıoglu M. U., Tezcanlı Tjon A Me E. K., Güral Z., Dizdar M. Y., et al.

ASTRO 2025, California, Amerika Birleşik Devletleri, 27 Eylül - 01 Ekim 2025, ss.1, (Özet Bildiri)

2. ONLİNE ADAPTİF RADYOTERAPİ UYGULANAN HASTALARDA İNTRAFRAKSİYONEL DEĞİŞİMİN REKTUM VE MESANE DOZ DAĞILIMINA ETKİSİ

Oskeroğlu Kaplan S., İspir E. B., Şenkesen Ö., Aydın İ., Tezcanlı Tjon A Me E. K., Abacıoglu M. U., et al.

16.Ulusal Radyasyon Onkolojisi Kongresi, Girne, Kıbrıs (Kktc), 9 - 13 Nisan 2025, cilt.40, sa.1, ss.222, (Özet Bildiri)

3. Evaluation of Set-Up Position Changes During Online Adaptive Therapy

Şenkesen Ö., İspir B., Aydın İ., Tezcanlı Tjon A Me E. K., Oskeroğlu S., Abacıoglu M. U., et al.

The European Society for Radiotherapy and Oncology (ESTRO), Glasgow, İngiltere, 3 - 07 Mayıs 2024, cilt.194, ss.4353-4354, (Özet Bildiri)

4. Dosimetric Comparision of VMAT and HyperArc Techniques for Multiple Brain Metastasis

İspir B., Şenkesen Ö., Özen Z., Aydın İ., Tezcanlı Tjon A Me E. K., Oskeroğlu S., et al.

The European Society for Radiotherapy and Oncology (ESTRO)2024, Glasgow, İngiltere, 3 - 07 Mayıs 2024, cilt.194, ss.3524-3525, (Özet Bildiri)

5. Enhanced Leaf Modeling Improves Dose Distribution and Treatment Efficiency in HyperArc-Based Management of Multiple Brain Metastases

İspir Aydınlıoğlu E. B., Şenkesen Ö., Tezcanlı E. K., Aydın İ., Abacıoğlu U.

2024 RSS Scientific Meeting, Illinois, Amerika Birleşik Devletleri, 21 Mart - 23 Nisan 2024, cilt.1, sa.1, ss.1, (Özet Bildiri)

6. Stereotactic MR-Guided Adaptive Radiotherapy (SMART) for Spine Metastases: Institutional Experience

Dincer N., Atalar B., Zoto Mustafayev T., Güngör G., Uğurluer G., Abacıoglu M. U., et al.

RSS Scientific Meeting, Illinois, Amerika Birleşik Devletleri, 21 - 23 Mart 2024, ss.1172, (Özet Bildiri)

7. MR Tabanli Günlük Adaptif Tedavide Planlanan Dozun, Uygulanan Toplam Doz Ve Predikte Edilen Dozlarla Karşılaştırılması

Türe A., Göksel E. O., Arifoğlu A., Oskeroğlu Kaplan S., Tezcanlı E., Abacıoglu M. U., et al.

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, cilt.1, ss.38, (Özet Bildiri)

8. Vajinal Karsinomda Brakiterapinin Yeri

Demircan N. V., Arifoğlu A., Mutaf S., Atahan C., Küçücük H., Göksel E. O., et al.

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, cilt.1, sa.1, ss.1, (Özet Bildiri)

9. Adrenal Bez Metastazlarının Tedavisinde Stereotaktik Mr Kılavuzluğunda Adaptif Radyoterapi

Mutaf S., Uğurluer G., Mustafayev T. Z., Dinçer N., Gungor G., Serkizyan A., et al.

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, ss.99, (Özet Bildiri)

10. Çoklu (≥3) Senkron/Metakron Akciğer Metastazlarına Yönelik Stereotaktik Vücut Radyoterapisi (SBRT)

Dinçer N., Mustafayev T. Z., Mutaf S., Serkizyan A., Abacıoglu M. U., Şengöz M., et al.

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, ss.61, (Özet Bildiri)

11. Prostat Kanseri Tedavisinde MR Kılavuzluğunda Online Adaptif Stereotaktik Vücut Radyoterapisi

Mustafayev T. Z., Uğurluer G., Atalar B., Güngör G., Dinçer N., Şengöz M., et al.

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, ss.14, (Özet Bildiri)

12. Akciğer Tümörlerinin Tedavisinde MR Kılavuzluğunda Online Adaptif Radyoterapi

Uğurluer G., Mustafayev T. Z., Gungor G., Serkizyan A., Abacıoglu M. U., Şengöz M., et al.

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, ss.49, (Özet Bildiri)

13. MRGRT: Neden Adapte Ediyoruz

Akgül B., Demircan V., Göksel E. O., Türe O. A., Arifoğlu A., Tezcanlı E., et al.

15. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, ss.53-54, (Özet Bildiri)

14. Nüks yüksek dereceli glioma hastalarında yeniden ışınlama sonuçları

Oskeroğlu Kaplan S., Demircan V., Tezcanlı E., Arifoğlu A., Şenkesen Ö., Özen Z., et al.

15.Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 6 - 10 Aralık 2023, cilt.1, sa.1, ss.1, (Özet Bildiri)

15. Tek İzomerkezli Çoklu Beyin Metastazı için VMAT ve HyperArc Tekniklerinin Dozimetrik Karşılaştırılması

Özen Z., İspir B., Şenkesen Ö., Aydın İ., Oskeroğlu Kaplan S., Tezcanlı E., et al.

19. Ulusal Medikal Fizik Kongresi, Muğla, Türkiye, 2 - 05 Kasım 2023, cilt.1, sa.1, ss.48, (Özet Bildiri)

16. Stereotactic Body Radiotherapy (SBRT) for Multiple (≥3) Synchronous/Metachronous Lung Metastasis

Dinçer N., Mustafayev T. Z., Mutaf S., Serkizyan A., Abacıoglu M. U., Şengöz M., et al.

2023 Radiosurgery Society Meeting, Florida, Amerika Birleşik Devletleri, 23 - 25 Mart 2023, cilt.15, sa.4, ss.890, (Özet Bildiri)

17. Stereotactic MR-guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Liver Metastases in Oligometastatic Patients

Uğurluer G., Atalar B., Mustafayev T. Z., Güngör G., Dinçer N., Mutaf S., et al.

2023 Radiosurgery Society Meeting, Florida, Amerika Birleşik Devletleri, 23 - 25 Mart 2023, cilt.15, ss.903, (Özet Bildiri)

18. Pediatrik pons yerleşimli H3K27M-Altere difüz orta hat gliomlarında stereotaktik biyopsi ve ONC-201 hedefe yönelik tedavi pratiği

TANRIKULU B., YAŞAR A., ERŞEN DANYELİ A., CANPOLAT C., ÇORAPÇIOĞLU F., TEZCANLI E., et al.

Türk Nöroşirürji Derneği 35.Bilimsel Kongresi, İstanbul, Türkiye, 24 Kasım 2022, (Tam Metin Bildiri)

19. Pediatrik Pons Yerleşimli H3K27-Altere Diffüz Orta Hat Gliomlarında Stereotaktik Biyopsi ve ONC201 Hedefe Yönelik Tedavi Pratiği

Tanrıkulu B., Yaşar A. H., Erşen Danyeli A., Canpolat C., Çorapçıoğlu F. V., Tezcanlı E. K., et al.

Türk Nöroşirürji Derneği 35. Bilimsel Kongresi, Antalya, Türkiye, 24 - 27 Kasım 2022, ss.1-2, (Özet Bildiri)

20. ATİPİK TERATOİD RABDOİD TÜMÖR: BEŞ OLGU SUNUMU

Demircan V., Tanrıkulu B., Tezcanlı E., Çorapçıoğlu F., Abacıoğlu U., Şengör M., et al.

24. Ulusal Kanser Kongresi, İstanbul, Türkiye, 9 - 13 Kasım 2022, ss.32, (Özet Bildiri)

21. PSA Kinetics and Outcomes after Magnetic Resonance Image-Guided Stereotactic Body Radiotherapy for Prostate Cancer

UĞURLUER G., Mustafayev T. Z., ATALAR B., GUNGOR G., Sengoz M., Abacioglu M. U., et al.

Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 23 - 26 Ekim 2022, (Özet Bildiri)

22. MR-Guided Online Adaptive Stereotactic Body Radiotherapy (SBRT) of Primary and Metastatic Lung Tumors

UĞURLUER G., Mustafayev T. Z., ABACIOGLU M. U., GUNGOR G., ŞENGÖZ K. M., ÖZYAR E., et al.

Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 23 - 26 Ekim 2022, (Özet Bildiri)

23. Oligometastazların Tedavisinde Stereotaktik MR Kılavuzluğunda Adaptif Radyoterapinin (SMART) Çok Merkezli Sonuçları

Chuong M. D., Herrera R., Mustafayev T. Z., Güngör G., Uğurluer G., Atalar B., et al.

14. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.8-9, (Özet Bildiri)

24. Adrenal metastazlarının tedavisinde MR kılavuzluğunda stereotaktik adaptif radyoterapinin dozimetrik ve klinik sonuçları

Uğurluer G., Serkizyan A., Zoto Mustafayev T., Atalar B., Abacıoğlu U., Şengör M., et al.

UROK 2021, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.78, (Özet Bildiri)

25. Pankreas tümörlerinin MR kılavuzluğunda online adaptif radyoterapi (SMART) ile tedavi sonuçları

Zoto Mustafayev T., Uğurluer G., Güngör G., Atalar B., Serkizyan A., Abacıoğlu U., et al.

UROK 2021, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.79, (Özet Bildiri)

26. Oligometastatik hastalarda karaciğer metastazlarının tedavisi için MR kılavuzluğunda online adaptif radyoterapi

Uğurluer G., Atalar B., Zoto Mustafayev T., Güngör G., Dincer N., Köken Ü., et al.

UROK 2021, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.56, (Özet Bildiri)

27. Prostat kanseri tedavisinde MR kılavuzluğunda online adaptif stereotaktik vücut radyoterapisi

Uğurluer G., Atalar B., Zoto Mustafayev T., Güngör G., Dincer N., Köken Ü., et al.

UROK 2021, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.51, (Özet Bildiri) Sürdürülebilir Kalkınma

28. Glioblastoma Tanılı Hastalarda Radyoterapi Sırasında Boost Hacmindeki Değişimin İncelenmesi

Şenkesen Ö., Tezcanlı E., Abacıoglu M. U., Özen Z., Çöne D., Küçücük H., et al.

14. Ulusal Radyasyon Onkolojisi Kongresi, Antalya, Türkiye, 26 - 30 Kasım 2021, ss.148, (Özet Bildiri)

29. TÜRKİYE’DEKİ RADYASYON ONKOLOGLARININ GLİOBLASTOMANIN TEDAVİSİNE YAKLAŞIMLARI: TROD 07-004 ÇALIŞMASI

ATASOY B. M., AKGÜN Z., ABACIOĞLU M. U.

14. ULUSAL RASYASYON ONKOLOJİSİ KONGRESİ, Antalya, Türkiye, 26 Kasım 2021, (Özet Bildiri)

30. Glioblastoma Hastalarında Adaptif Radyoterapi: Hedef Hacim ve Risk Altındaki Organ Dozları Değişimi

Şenkesen Ö., Tezcanlı E., Abacıoglu M. U., Özen Z., Küçücük H., Göksel E. O., et al.

18.Medikal Fizik Kongresi, Antalya, Türkiye, 4 - 07 Kasım 2021, cilt.1, sa.1, ss.112-115, (Özet Bildiri)

31. Dosimetric and Clinical Evaluation of Stereotactic MR-guided Online Adaptive Radiation Therapy (SMART) for Treatment of Adrenal Metastases

Uğurluer G., Serkizyan A., Zoto Mustafayev T., Atalar B., Abacıoğlu M. U., Güngör G., et al.

ASTRO 63rd Annual Meeting, Illinois, Amerika Birleşik Devletleri, 24 - 27 Ekim 2021, ss.27, (Özet Bildiri)

32. Effect of Small Field Dosimetry on Stereotactic Radiosurgery Treatment Plans

Şenkesen Ö., Özen Z., Göksel E. O., Küçücük H., Tezcanlı E., Abacıoglu M. U.

AAPM Virtual Spring Clinical Meeting, Virginia, Amerika Birleşik Devletleri, 17 - 21 Nisan 2021, ss.3, (Özet Bildiri)

33. Feasibility of Stereotactic MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer

Mustafayev T. Z., Atalar B., Gungor G., Sengoz M., Abacioglu U., Ozyar E.

62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 25 - 28 Ekim 2020, cilt.108, (Özet Bildiri) Sürdürülebilir Kalkınma

34. Treatment Results of Pediatric Posterior Fossa Ependymomas according to Molecular Subtypes

Abacioglu U., TANRIKULU B., Danyeli A. E., CANPOLAT C., Sengoz M., ÖZEK Ö. M. M.

62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 25 - 28 Ekim 2020, cilt.108, (Özet Bildiri)

35. Time Analysis in Magnetic Resonance Image-Guided Radiotherapy Workflow

Mustafayev T. Z., Sahin B., Gungor G., Aydin G., Serbez I., Teymur B., et al.

61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Illinois, Amerika Birleşik Devletleri, 15 - 18 Eylül 2019, cilt.105, (Özet Bildiri)

36. IS THE PATHOLOGICAL-GRADE RELEVANT IN "IDH-WILD TYPE, TERT-MUTANT" DIFFUSE-GLIOMAS? AN ANALYSIS IN 147 PATIENTS

Danyeli A., Akyerli C., DİNÇER A., Cosgun E., Abacioglu U., PAMİR M. N., et al.

14th Meeting of the European-Association-of-Neuro-Oncology (EANO), Lyon, Fransa, 19 - 22 Eylül 2019, cilt.21, ss.90, (Özet Bildiri)

37. Urethra-sparing SBRT for prostate cancer: quality assurance of a randomized phase II trial

Jaccard M., Zilli T., Dubouloz A., Tsang L., Zvi S., Linthout N., et al.

38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan, İtalya, 26 - 30 Nisan 2019, cilt.133, (Özet Bildiri) Sürdürülebilir Kalkınma

38. Medically Inoperable Early-Stage Lung Cancer Treated with Stereotactic Ablative Radiation Therapy (SABR): Multicenter Study of Turkish Radiation Oncology Group (TROG)

ATALAR B., KAYTAN SAĞLAM E., Akgun Z., ABACIOGLU M. U., Arifoglu A., Sahin B., et al.

60th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), San-Antonio, Kuzey Mariana Adaları, 21 - 24 Ekim 2018, cilt.102, (Özet Bildiri)

39. Weekly vs. every-other-day prostate cancer SBRT: 18-months results from a randomized phase II trial

Zilli T., Jorcano S., Bral S., Rubio C., Bruynzeel A., Oliveira A., et al.

37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Barcelona, İspanya, 20 - 24 Nisan 2018, cilt.127, (Özet Bildiri) Sürdürülebilir Kalkınma

40. Short vs protracted urethra-sparing prostate SBRT: feasibility and early toxicity from a randomized phase II trial

Kountouri M., Zilli T., Bruynzeel A., Minn H., Sanchez-Saugar E., Oliveira A., et al.

19th Annual Meeting of the Scientific-Association-of-Swiss-Radiation-Oncology (SASRO), Basel, İsviçre, 11 - 13 Haziran 2015, cilt.191, ss.902, (Özet Bildiri)

41. Comparison of Target Volume and Organ at Risk Doses With Multichannel Versus Single Channel Cylinder for Vaginal Brachytherapy

Abacioglu M. U., Ozen Z., Hancilar N., Arifoglu A., Gunhan B., Ibrahimov R., et al.

56th Annual Meeting of the American-Society-for-Radiation-Oncology, San-Francisco, Kostarika, 14 - 17 Eylül 2014, cilt.90, (Özet Bildiri)

42. Urethra-Sparing Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Dosimetric Results From a Prospective Multicenter Randomized Phase 2 Trial

Zilli T., Tsvang L., Symon Z., Abacioglu U., Bruynzeel A., Rouzaud M., et al.

56th Annual Meeting of the American-Society-for-Radiation-Oncology, San-Francisco, Kostarika, 14 - 17 Eylül 2014, cilt.90, (Özet Bildiri) Sürdürülebilir Kalkınma

43. Intrakranial Küçük Hacimli Bening Tümörlerde Gamma Knife ve Linak Tabanlı Düzleştirici Filtre ile Filtresiz Stereotaktik Radyocerrahi Tedavi Planlarında Doz Dağılımlarının Karşılaştırılması

Yılmaz M., Şenkesen Ö., Tezcanlı E., Küçücük,Küçücük H., Göksel E. O., Çöne D., et al.

14.Ulusal Medikal Fizik Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2013, ss.19, (Özet Bildiri)

44. Head and Neck IMRT With or Without Flattening Filter: A Dosimetric Comparison

Abacioglu M. U., Unal S., Ozen Z., Gunhan B., Gurdalli S., Arifoglu A.

54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), Massachusetts, Amerika Birleşik Devletleri, 28 - 31 Ekim 2012, cilt.84, (Özet Bildiri)

45. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

Dane F., Atasoy B. M., Akgun Z., Yumuk F., Cabuk D., Teomete M., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, cilt.30, (Özet Bildiri)

46. Lokal İleri Rektum Kanserinin Neoadjuvan Radyoterapisinde Volumetrik Ark Tedavisinin Konformal Tekniklerle Dozimetrik Karşılaştırılması

AKGÜN Z., YÜCEL S., TURAN S., ÖZEN Z., LİKOĞLU F., EZGİ C., et al.

10. Ulusal Radyasyon Onkolojisi Kongresi, Türkiye, 19 - 23 Nisan 2012 Sürdürülebilir Kalkınma

47. RADIOTHERAPY WITH OR WITHOUT TEMOZOLOMIDE IN ELDERLY GLIOBLASTOMA PATIENTS: PERFORMANCE OR AGE AS A SURROGATE?

Dirier A., ABACIOGLU M. U., Okkan S., Pak Y., Guney Y. Y., AKSU M. G., et al.

Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference, Florida, Amerika Birleşik Devletleri, 9 - 12 Aralık 2010, cilt.12, ss.42, (Özet Bildiri)

48. QUALITY OF LIFE RESULTS OF AN EORTC PHASE III RANDOMIZED TRIAL OF ADJUVANT WHOLE-BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGICAL RESECTION OF 1-3 CEREBRAL METASTASES OF SOLID TUMORS

Soffietti R., Mueller R. P., ABACIOGLU M. U., Villa S., Fauchon F., Baumert B., et al.

49. GLIOBLASTOMA IN ELDERLY PATIENTS: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN A RANDOMIZED TRIAL COMPARING 6-WEEKS OF TADIOTHERAPY (RT) VS HYPOFRACTIONATED RT OVER 2 WEEKS VS TEMOZOLOMIDE CHEMOTHERAPY (TMZ)

Malmstrom A., Gronberg B., Stupp R., Marosi C., Frappaz D., Schultz H., et al.

9th Meeting of European-Association-of-NeuroOncology, Maastricht, Hollanda, 16 - 19 Eylül 2010, cilt.12, ss.18-19, (Özet Bildiri)

50. SINGLE CENTER SURVIVAL OUTCOMES OF 167 GLIOBLASTOMA PATIENTS: BEFORE AND AFTER TEMOZOLOMIDE

ABACIOGLU M. U., ÜÇÜNCÜ KEFELİ A., Akgun Z., Caglar H., Atasoy B., Yumuk F., et al.

3rd Quadrennial Meeting of the World-Federation-of-Neuro-Oncoloyg/6th Meeting of the Asian-Society-for-Neuro-Oncology, Yokohama, Japonya, 11 - 14 Mayıs 2009, cilt.11, ss.936, (Özet Bildiri)

51. WHOLE-BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGERY OF 1-3 BRAIN METASTASES-RESULTS OF THE EORTC 22952-26001 PHASE III STUDY

Soffietti R., Kocher M., Colette S., Abacioglu M. U., Villa S., Fauchon F., et al.

3rd Quadrennial Meeting of the World-Federation-of-Neuro-Oncoloyg/6th Meeting of the Asian-Society-for-Neuro-Oncology, Yokohama, Japonya, 11 - 14 Mayıs 2009, cilt.11, ss.899, (Özet Bildiri)

52. ADJUVANT WHOLE BRAIN RADIOTHERAPY VERSUS OBSERVATION AFTER RADIOSURGERY OR SURGICAL RESECTION OF 1-3 CEREBRAL METASTASES-RESULTS OF THE EORTC 22952-26001 STUDY

Soffietti R., Mueller R., Abacioglu M. U., Villa S., Fauchon F., Baumert B., et al.

Joint Meeting of the Society-forNeuro-Oncology/American-Association-of-Neurological -Surgeons/Congress of Neurological Surgeons, Louisiana, Amerika Birleşik Devletleri, 22 - 24 Ekim 2009, cilt.11, ss.662-663, (Özet Bildiri)

53. Adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases - results of the EORTC 22952-26001 study

Soffietti R., Mueller R. P., Abacioglu M. U., Villa S., Fauchon F., Baumert B. G., et al.

15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, Berlin, Almanya, 20 - 24 Eylül 2009, cilt.7, ss.495, (Özet Bildiri)

54. The Evaluation of the Efficacy of Chemoradiotherapy(CRT) following Neo-adjuvant Treatment with Docetaxel(T)-Cisplatin(P) in Undifferentiated and Nonkeratinized Squamous Cell Carcinoma of the Nasopharynx - Phase IV Clinical Trial: A Turkish Oncology Group Study

Uzel O. E., ÖZYAR E., Pak Y., ABACIOGLU M. U., ALTUN M., KAPLAN B., et al.

51st Annual Meeting of the American-Society-for-Radiation-Oncology, Illinois, Amerika Birleşik Devletleri, 1 - 05 Kasım 2009, cilt.75, (Özet Bildiri)

55. Adjuvant Whole Brain Radiotherapy vs. Observation after Radiosurgery or Surgical Resection of 1-3 Cerebral Metastases - Results of the EORTC 22952-26001 Study

Kocher M., Mueller R. P., Abacioglu M. U., Villa S., Fauchon F., Baumert B. G., et al.

51st Annual Meeting of the American-Society-for-Radiation-Oncology, Illinois, Amerika Birleşik Devletleri, 1 - 05 Kasım 2009, cilt.75, (Özet Bildiri)

56. Effect of Time Interval between Surgical Resection and Radiotherapy on Survival of Patients with Glioblastoma

Abacioglu M. U., Akgun Z., ÜÇÜNCÜ KEFELİ A., ATASOY B. M., Caglar H. B.

51st Annual Meeting of the American-Society-for-Radiation-Oncology, Illinois, Amerika Birleşik Devletleri, 1 - 05 Kasım 2009, cilt.75, (Özet Bildiri)

57. Three dimensinal non coplanar irradiation for right hemitorasic tumors of operated malignant mesothelioma

Oezen Z., Caglar H., Akgun A., ABACIOGLU M. U.

9th Biennial Meeting on Physics and Radiation Technology for Clinical Radiotherapy, Barcelona, İspanya, 8 - 13 Eylül 2007, cilt.84, (Özet Bildiri)

58. Assessment of toxicity and the factors limiting concomitant radiochemotherapy in squamous cell carcinoma of head and neck (HNSCC)

ATASOY B. M., Dane F., Ozen Z., Akgun Z., Yumuk F., ABACIOGLU M. U.

International Meeting on Innovative Approaches in Head and Neck Oncology, Barcelona, İspanya, 22 - 27 Şubat 2007, cilt.82, (Özet Bildiri)

59. Concurrent administration of urasil-tegafur and folinic acid with radiation for locally advanced rectum cancer: Tolerability and quality of life assessments

Atasoy B. M., ABACIOGLU M. U., Ozgen Z., Dane F., Yumuk F. P., Akgun Z., et al.

25th Congress of the European-Society-for-Therapeutic-Radiology-and-Oncology, Leipzig, Almanya, 8 - 12 Ekim 2006, cilt.81, (Özet Bildiri)

60. Information needs of early-stage prostate cancer patients: A comparison of seven European countries and Canada.

Capirci C., Feld Man-Stewart D., Abacioglu U., Gawkowska-Suwinska M., van Gils F., Heyda A., et al.

25th Congress of the European-Society-for-Therapeutic-Radiology-and-Oncology, Leipzig, Almanya, 8 - 12 Ekim 2006, cilt.81, (Özet Bildiri) Sürdürülebilir Kalkınma

61. Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

Teomete M., Yumuk P. F., Iyikesici M. S., Dane F., Basaran G., Cabuk D., et al.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.225-226, (Özet Bildiri)

62. Adjuvant comcomittant administration of urasil-tegafur (UFT) and folinic acid (FA) during irradiation for locally advanced rectum cancer: Tolerability assessment

Atasoy B. M., ABACIOGLU M. U., Ozgen Z., Dane F., Yumuk P. F., Akgun Z., et al.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.134, (Özet Bildiri)

63. Treatment results of 165 pediatric patients with non metastatic nasopharyngeal carcinoma a rare cancer network study (sözlü sunum)

Özyar E., Selek U., Laskar S., Uzel Ö. E., Anacak Y., Myriam B., et al.

Proc. ECCO 13-the European Cancer Conference, Paris, France, 30 October-3 November (Sözlü sunum), 2005, Paris, Fransa, 30 Ekim - 03 Kasım 2005, cilt.3, ss.354, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

64. Treatment results of 165 pediatric patients with non metastatic nasopharyngeal carcinoma A rare cancer network study (sözlü sunum)

Özyar E., Selek U., Laskar S., Uzel Ö. E., Anacak Y., Myriam B., et al.

Proc. 47th Annual Meeting of the American Society of Therapeutic Radiology, Denver, Colorado, 16-20 October, 2005, Colorado, Amerika Birleşik Devletleri, 16 - 20 Ekim 2005, cilt.63, ss.23, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

65. Gamma Knife stereotactic radiosurgery in nasopharyngeal carcinoma

ATASOY B. M., PEKER S., ŞENGÖZ K. M., ABACIOĞLU U., KILIÇ T., PAMİR M. N.

ECCO 2005, 15 - 16 Ekim 2005, (Özet Bildiri)

66. Prognostic significance of MIB-1 labeling indices for oligodendroglial tumors

Abacioglu U., Sengoz M., Tezcanli E., Akpulat S., Peker S., Sav A.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, Amerika Birleşik Devletleri, 13 - 17 Mayıs 2005, cilt.23, (Özet Bildiri)

67. Ki-67 proliferation index as a marker for clinical radioresponse in glioblastoma multiforme

Abacioglu U., Gucluer B., Cetin I., Akgun Z., Tezcanli E., Sengoz M., et al.

47th Annual Meeting of the American-Society-for-Therapeutic-Radiology-and-Oncology, Colorado, Amerika Birleşik Devletleri, 16 - 20 Ekim 2005, cilt.63, (Özet Bildiri)

68. Memenin İnvazif Duktal Karsinomlarında p 53 ve c erbB 2 Onkogenlerinin Ekspresyonunun Östrojen Progesteron Reseptörleri ve Histopatolojik Parametrelerle İlişkisi

KAYA H., ERBARUT İ., GÜLLÜOĞLU M. B., ÇAĞLAR H., ABACIOĞLU U., ÖZKAN N., et al.

17. Ulusal Patoloji Sempozyumu, Türkiye, 1 - 06 Ekim 2004

69. Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC).

ABACIOGLU M. U., Yumuk P., Caglar H., Sengoz M., Turhal N.

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)

70. Is the incidence of anal canal cancers different in Moslem societies?

Cabuk D., Yumuk P., ABACIOGLU M. U., Demir G., Dane F., Gumus M., et al.

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Haziran 2004, cilt.22, (Özet Bildiri)

71. The outcomes of patients with trigeminal Schwannoma after stereotactic radiosurgery

Atasoy B., Peker S., ABACIOGLU M. U., Kilic T., Sengoz M., Pamir N.

2nd ESTRO Meeting on Radiotherapy for Non-Malignant Diseases, Nice, Fransa, 1 - 03 Nisan 2004, cilt.71, (Özet Bildiri)

Kitaplar 6

1. Moleküler görüntülemenin akciğer kanserli hastalarda radyoterapi planlaması ve tedavi yanıtının değerlendirilmesine katkısı

Demircan V., Abacioglu M. U.

Akciğer Kanserlerinde Güncel Moleküler Görüntüleme Uygulamaları, Vardareli E, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.66-71, 2024

Metrikler

Yayın

205

Yayın (WoS)

124

Yayın (Scopus)

Atıf (WoS)

4368

H-İndeks (WoS)

Atıf (Scopus)

5398

H-İndeks (Scopus)

Atıf (Scholar)

7499

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler